Summit X LLC’s Labcorp LH Stock Holding History

Summit X LLC’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,141	Closed	-$237K	–	239
2023 Q2	$237K	Buy	+1,141	New	+$221K	0.06%	243

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Summit X LLC's LH Position: Q3 2023 in Review

Summit X LLC sold out of Labcorp (LH) in Q3 2023, closing a stake of 1,141 shares — an estimated $237K sold.

Summit X LLC first reported a position in LH in Q2 2023 and held it in 1 quarter. The position peaked at $237K in Q2 2023. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.

Summit X LLC reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
Summit X LLC sold 1,141 Labcorp shares in Q3 2023, an estimated $237K.
Summit X LLC first reported a position in Labcorp in Q2 2023 and held it in 1 quarter.
Summit X LLC's Labcorp position peaked at $237K in Q2 2023.
881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on Summit X LLC's 13F filing for Q3 2023, filed 6 Nov 2023.